Vanguard Capital Management
TRAW icon

Vanguard Capital Management’s Traws Pharma TRAW Stock Holding History

Vanguard Capital Management’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$278K Buy
330,049
+274,856
+498% +$379K ﹤0.01% 3792
2026
Q1 		$101K Buy
+55,193
New +$104K ﹤0.01% 3864

Other funds holding TRAW

ABG
Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return

Vanguard Capital Management's TRAW Position: Q2 2026 in Review

Vanguard Capital Management increased its Traws Pharma (TRAW) stake by 498% in Q2 2026, buying an estimated $379K and bringing the position to 330,049 shares worth $278K. The position accounts for ﹤0.01% of the portfolio, ranked #3792.

Vanguard Capital Management first reported a position in TRAW in Q1 2026 and has held it in 2 quarters since. 30 funds tracked by Wall St. Rank hold TRAW as of Q2 2026.

  • Vanguard Capital Management held 330,049 shares of Traws Pharma worth $278K as of Q2 2026.
  • Vanguard Capital Management bought 274,856 Traws Pharma shares in Q2 2026, an estimated $379K.
  • Traws Pharma made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3792 holding.
  • Vanguard Capital Management first reported a position in Traws Pharma in Q1 2026 and has held it in 2 quarters since.
  • 30 funds tracked by Wall St. Rank held Traws Pharma as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.